Stock Hong Kong Stock Shock | China Shijie Group (01093.HK) soared more than 14% after the performance announcement. Licensing fees offset the decline in drug sales revenue, which is expected to become a new growth driver.

According to the Securities Times APP, SinoPharm Group (01093.HK) released its performance at noon, with a soaring of over 14% in the afternoon. As of the time of publication, it has risen by 11.88%, reaching 7.62 Hong Kong dollars, with a trading volume of 2.151 billion Hong Kong dollars.